Gilead Announces $8m in Grant Funding for Viral Hepatitis Relink Program in the US
Funding Will Support the Re-Engagement of Diagnosed but Untreated People Living with HCV and HBV in the United…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jul 23
Funding Will Support the Re-Engagement of Diagnosed but Untreated People Living with HCV and HBV in the United…
20 Jul 23
According to the trial's primary outcome measures, CoronaTcP showed a satisfactory safety profile, with no serious adverse events…
20 Jul 23
The Series B funding round was led by Bioluminescence Ventures, with participation from KdT Ventures, Piedmont Capital, and…
20 Jul 23
The oral levosimendan treatment for PH-HFpEF is covered by the issued patent (US Patent No. 11,701,355), which grants…
20 Jul 23
The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis…
20 Jul 23
On 5 May 2023, France reported an increase in cases of severe neonatal sepsis associated with Enterovirus (Echovirus-11…
19 Jul 23
Emory Hernandez Valadez claims that heavy exposure to the company's talc starting in his early years led to…
19 Jul 23
The products involved in the deal include FLAREX, NATACYN, TOBRADEX ST, VERKAZIA, ZERVIATE, and non-prescription brands FRESHKOTE and…
19 Jul 23
In a Phase 2 study, navacaprant (NMRA-140) monotherapy demonstrated statistically significant and clinically meaningful reductions in symptoms of…
19 Jul 23
New partnership with Niba Labs to offer customized digital PCR (dPCR) assay design services to biopharma customers. Launch…